Ozempic: payments to doctors
Payments that named Ozempic as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $69.2M
- Providers
- 171,298
- Transactions
- 1,966,239
- Average per transaction
- $35
The per-transaction average — $35 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 171,298 providers the average total is $404, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novo Nordisk | $68,960,665 | 99.6% |
| Novo Nordisk AS | $246,438 | 0.4% |